Yan-dong D. Wang

State Key Laboratory Of Chemical Resource Engineering
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Amino acid metabolic reprogramming by gut microbiota: a novel metabolic checkpoint in the tumor microenvironment.

Amino acid metabolic reprogramming by gut microbiota: a novel metabolic checkpoint in the tumor microenvironment.

Journal: Gut microbes

Published: August 18, 2026

Monoaminylation in Human Health and Disease: State of the Field, Challenges, and Emerging Directions.

Monoaminylation in Human Health and Disease: State of the Field, Challenges, and Emerging Directions.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 16, 2025

Epigenetic orchestrator and drug enhancer: dual roles of butyrate in regulating post-translational modification and optimizing therapeutic delivery.

Epigenetic orchestrator and drug enhancer: dual roles of butyrate in regulating post-translational modification and optimizing therapeutic delivery.

Journal: Cell communication and signaling : CCS

Published: July 31, 2025

Sulforaphane targets STAT3-CKMT2-AS1 to suppress gastric cancer via PSMB8 downregulation and AIMP1 stabilization.

Sulforaphane targets STAT3-CKMT2-AS1 to suppress gastric cancer via PSMB8 downregulation and AIMP1 stabilization.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: July 02, 2025

Targeting tRNA-dependent tyrosine usage unveils a metabolic vulnerability in hepatocellular carcinoma.

Targeting tRNA-dependent tyrosine usage unveils a metabolic vulnerability in hepatocellular carcinoma.

Journal: Nature communications

Published: June 24, 2025

Sulforaphane inhibits gastric cancer progression by regulating the YY1/PSMB8-AS1/miR-888-5p/SLC4A7 axis.

Sulforaphane inhibits gastric cancer progression by regulating the YY1/PSMB8-AS1/miR-888-5p/SLC4A7 axis.

Journal: Biochemical and biophysical research communications

Published: April 22, 2025

Editorial: Gut microbiota and gastrointestinal disorders, volume II.

Editorial: Gut microbiota and gastrointestinal disorders, volume II.

Journal: Frontiers in medicine

Published: February 13, 2025

Design, Synthesis, and Biological Evaluation of Covalently Mucoadhesive Derivatives as Nonsystemic Intestine-Targeted TGR5 Agonists.

Design, Synthesis, and Biological Evaluation of Covalently Mucoadhesive Derivatives as Nonsystemic Intestine-Targeted TGR5 Agonists.

Journal: Journal of medicinal chemistry

Published: September 25, 2024

Farnesoid X receptor activation alleviates hepatic encephalopathy by improving hepatic ammonia metabolism in murine models.

Farnesoid X receptor activation alleviates hepatic encephalopathy by improving hepatic ammonia metabolism in murine models.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: September 17, 2024

Activation of the G Protein-Coupled Bile Acid Receptor TGR5 Modulates the HCP5/miR-139-5p/DDIT4 Axis to Antagonize Cervical Cancer Progression.

Activation of the G Protein-Coupled Bile Acid Receptor TGR5 Modulates the HCP5/miR-139-5p/DDIT4 Axis to Antagonize Cervical Cancer Progression.

Journal: International journal of molecular sciences

Published: July 10, 2024

Heparan sulfate-dependent phase separation of CCL5 and its chemotactic activity.

Heparan sulfate-dependent phase separation of CCL5 and its chemotactic activity.

Journal: eLife

Published: July 01, 2024

A MYC-STAMBPL1-TOE1 positive feedback loop mediates EGFR stability in hepatocellular carcinoma.

A MYC-STAMBPL1-TOE1 positive feedback loop mediates EGFR stability in hepatocellular carcinoma.

Journal: Cell reports

Published: December 29, 2023

Showing 1-12 of 63

Last Updated: 09/26/2026